These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10506130)

  • 1. Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin/proteasome-dependent regulation.
    Tintut Y; Parhami F; Le V; Karsenty G; Demer LL
    J Biol Chem; 1999 Oct; 274(41):28875-9. PubMed ID: 10506130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation.
    Zhao M; Qiao M; Oyajobi BO; Mundy GR; Chen D
    J Biol Chem; 2003 Jul; 278(30):27939-44. PubMed ID: 12738770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin-proteasome system and cellular proliferation and regulation in osteoblastic cells.
    Murray EJ; Bentley GV; Grisanti MS; Murray SS
    Exp Cell Res; 1998 Aug; 242(2):460-9. PubMed ID: 9683533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3',5'-Cyclic adenosine monophosphate activation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro.
    Koh AJ; Beecher CA; Rosol TJ; McCauley LK
    Endocrinology; 1999 Jul; 140(7):3154-62. PubMed ID: 10385409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells.
    Shui C; Spelsberg TC; Riggs BL; Khosla S
    J Bone Miner Res; 2003 Feb; 18(2):213-21. PubMed ID: 12568398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient suppression of core-binding factor alpha 1 expression by basic fibroblast growth factor in rat osteoblast-like osteosarcoma ROS17/2.8 cells.
    Tsuji K; Noda M
    J Bone Miner Metab; 2001; 19(4):213-9. PubMed ID: 11448013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism.
    Bellido T; Ali AA; Plotkin LI; Fu Q; Gubrij I; Roberson PK; Weinstein RS; O'Brien CA; Manolagas SC; Jilka RL
    J Biol Chem; 2003 Dec; 278(50):50259-72. PubMed ID: 14523023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.
    Gu K; Zhang L; Jin T; Rutherford RB
    Cells Tissues Organs; 2004; 176(1-3):28-40. PubMed ID: 14745233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone enhances In vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells.
    Mori K; Shioi A; Jono S; Nishizawa Y; Morii H
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2112-8. PubMed ID: 10479652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genistein stimulates osteoblastic differentiation via p38 MAPK-Cbfa1 pathway in bone marrow culture.
    Liao QC; Xiao ZS; Qin YF; Zhou HH
    Acta Pharmacol Sin; 2007 Oct; 28(10):1597-602. PubMed ID: 17883946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
    Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
    Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts.
    Viereck V; Siggelkow H; Tauber S; Raddatz D; Schutze N; Hüfner M
    J Cell Biochem; 2002; 86(2):348-56. PubMed ID: 12112004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
    Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
    Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cbfa1 isoform overexpression upregulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells.
    Xiao ZS; Hinson TK; Quarles LD
    J Cell Biochem; 1999 Sep; 74(4):596-605. PubMed ID: 10440929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5.
    Nishimura R; Hata K; Harris SE; Ikeda F; Yoneda T
    Bone; 2002 Aug; 31(2):303-12. PubMed ID: 12151083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of the inducible cAMP early repressor (ICER) by the ubiquitin-proteasome pathway.
    Folco EJ; Koren G
    Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):37-43. PubMed ID: 9359831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha.
    Gilbert L; He X; Farmer P; Rubin J; Drissi H; van Wijnen AJ; Lian JB; Stein GS; Nanes MS
    J Biol Chem; 2002 Jan; 277(4):2695-701. PubMed ID: 11723115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the PEBP2alphaA/AML3/CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type I collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells.
    Tsuji K; Ito Y; Noda M
    Bone; 1998 Feb; 22(2):87-92. PubMed ID: 9477230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The promyelotic leukemia zinc finger promotes osteoblastic differentiation of human mesenchymal stem cells as an upstream regulator of CBFA1.
    Ikeda R; Yoshida K; Tsukahara S; Sakamoto Y; Tanaka H; Furukawa K; Inoue I
    J Biol Chem; 2005 Mar; 280(9):8523-30. PubMed ID: 15623533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling.
    Krishnan V; Moore TL; Ma YL; Helvering LM; Frolik CA; Valasek KM; Ducy P; Geiser AG
    Mol Endocrinol; 2003 Mar; 17(3):423-35. PubMed ID: 12554794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.